🇺🇸 FDA

Company profile · Sponsor

Shanghai

Shanghai University of Traditional Chinese Medicine

CF7B702 · NMPA pharma CN
Pipeline
24
Drugs
0
Patents
0

Quick answer

Shanghai (CF7B702) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CF7B702
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (24)

Search pipeline →

  1. GV-971

    Shanghai

    Alzheimer Disease

    phase 3 small molecule on hold

    1 trial

  2. JS001

    Shanghai

    Triple-Negative Breast Cancer

    phase 3 small molecule completed

    1 trial

  3. Sodium Thiosulfate Injection

    Shanghai

    Hepatoblastoma

    phase 3 small molecule active

    1 trial

  4. AK0529

    Shanghai

    RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

    phase 2 small molecule completed

    1 trial

  5. EMB-01

    Shanghai

    Neoplasms

    phase 2 small molecule active

    1 trial

  6. Furmonertinib

    Shanghai

    Lung Adenocarcinoma Stage III

    phase 2 small molecule active

    1 trial

  7. JMT108

    Shanghai

    Unresectable Locally Advanced or Metastatic Melanoma

    phase 2 small molecule active

    1 trial

  8. MRG003

    Shanghai

    Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

    phase 2 small molecule active

    1 trial

  9. SR419

    Shanghai

    Peripheral Neuropathic Pain

    phase 2 small molecule completed

    1 trial

  10. TQC2731 injection

    Shanghai

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule active

    1 trial

  11. TQH2722 injection

    Shanghai

    Seasonal Allergic Rhinitis

    phase 2 small molecule active

    1 trial

  12. cis Platinum/Carboplatin, Pemetrexed Disodium

    Shanghai

    Chemotherapy, Adjuvant

    phase 2 small molecule active

    1 trial

  13. 9MW3811 injection

    Shanghai

    Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  14. Donepezil Dihydroxynaphthalate for Injection

    Shanghai

    Alzheimer Disease

    phase 1 small molecule active

    1 trial

  15. HB0056

    Shanghai

    Healthy

    phase 1 small molecule active

    1 trial

  16. JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells)

    Shanghai

    Diffuse Large B Cell Lymphoma

    phase 1 mab completed

    1 trial

  17. MWN109 tablet

    Shanghai

    Overweight or Obesity

    phase 1 small molecule active

    1 trial

  18. Qing'E pill

    Shanghai

    Menopause

    phase 1 small molecule completed

    1 trial

  19. Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo

    Shanghai

    Healthy

    phase 1 small molecule completed

    1 trial

  20. Recombinant oncolytic herpes simplex virus type Ⅰ (R130)

    Shanghai

    Osteosarcoma

    phase 1 small molecule active

    1 trial

  21. SCT-001 CAR-T cells

    Shanghai

    Ovarian Cancer

    phase 1 mab active

    1 trial

  22. SYHA1813 oral solution (2.0g:25mg)

    Shanghai

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  23. TQB2825 Injection (Subcutaneous Injection)

    Shanghai

    CD20-positive Hematological Malignancies

    phase 1 small molecule active

    1 trial

  24. YZJ-1139 tablets

    Shanghai

    Insomnia

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Shanghai?

Shanghai (CF7B702) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Shanghai sponsor?

We track 24 ClinicalTrials.gov-linked programs for Shanghai, including GV-971 and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Shanghai company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.